NYMOX PHARM CORP by Nymox Pharmaceutical Corp. (NYMXF)

About NYMOX PHARM CORP by Nymox Pharmaceutical Corp. (NYMXF)

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

NYMOX PHARM CORP by Nymox Pharmaceutical Corp. News